122 related articles for article (PubMed ID: 11426190)
1. Pegylated interferon (PEG-Intron) for chronic hepatitis C.
Med Lett Drugs Ther; 2001 Jun; 43(1107):54-5. PubMed ID: 11426190
[No Abstract] [Full Text] [Related]
2. [Treatment of chronic hepatitis C with pegylated alpha-interferons].
Niederau C
Dtsch Med Wochenschr; 2002 Mar; 127(11):563-6. PubMed ID: 11894177
[No Abstract] [Full Text] [Related]
3. [Pegylated interferon sets a new standard. Better prognosis for hepatitis C infected patients].
MMW Fortschr Med; 2002 May; 144(21):56. PubMed ID: 12138886
[No Abstract] [Full Text] [Related]
4. A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group.
Glue P; Rouzier-Panis R; Raffanel C; Sabo R; Gupta SK; Salfi M; Jacobs S; Clement RP
Hepatology; 2000 Sep; 32(3):647-53. PubMed ID: 10960463
[TBL] [Abstract][Full Text] [Related]
5. [Pegylated interferon alfa-2a. Improved prognosis in hepatitis C].
MMW Fortschr Med; 2002 Sep; 144(38):59. PubMed ID: 12395712
[No Abstract] [Full Text] [Related]
6. PEG-IFN, RBV dosing during chronic HCV re-treatment.
Highleyman L
IAPAC Mon; 2007 Feb; 13(2):55. PubMed ID: 17948601
[No Abstract] [Full Text] [Related]
7. Phase III Peg-Intron plus Rebetol results released.
AIDS Read; 2000 Dec; 10(12):702. PubMed ID: 11189740
[No Abstract] [Full Text] [Related]
8. Treating hepatitis C: are children the same as adults?
Delgado-Borrego A
Gastroenterology; 2011 Feb; 140(2):389-92. PubMed ID: 21172331
[No Abstract] [Full Text] [Related]
9. Pegylated interferon for treatment in hemodialysis patients with chronic hepatitis C.
Koksal I
J Gastroenterol Hepatol; 2006 Mar; 21(3):491-4. PubMed ID: 16638088
[No Abstract] [Full Text] [Related]
10. [High dose repeat therapy in previously treated patients with chronic hepatitis C].
Hoepffner N; Paul KA; Nikodem AB; Teuber G
Dtsch Med Wochenschr; 2006 Mar; 131(11):543-4. PubMed ID: 16538557
[No Abstract] [Full Text] [Related]
11. [APRICOT Study evaluated. Surprisingly high virologic response in HIV-HCV coinfection].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():74-5. PubMed ID: 15373058
[No Abstract] [Full Text] [Related]
12. Response-guided therapy: optimizing treatment now and in the future.
Marcellin P; Rizzetto M
Antivir Ther; 2008; 13 Suppl 1():1-2. PubMed ID: 18432156
[No Abstract] [Full Text] [Related]
13. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
14. Pushing the treatment envelope for chronic hepatitis C--is more necessarily better?
Lutchman G; Ghany M
Hepatology; 2005 Feb; 41(2):234-6. PubMed ID: 15657958
[No Abstract] [Full Text] [Related]
15. [Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
Enjoji M; Dainichi T; Gondo H; Urabe K
Fukuoka Igaku Zasshi; 2007 Sep; 98(9):353-6. PubMed ID: 17974079
[TBL] [Abstract][Full Text] [Related]
16. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
Demirturk N; Aykin N; Demirdal T; Cevik F
Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483
[No Abstract] [Full Text] [Related]
17. Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C.
McHutchison J; Sulkowski M
J Viral Hepat; 2008 Jul; 15(7):475-81. PubMed ID: 18363672
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis.
Meyer-Wyss B; Rich P; Egger H; Helbling B; Müllhaupt B; Rammert C; Gonvers JJ; Oneta C; Criblez D; Rossi L; Borovicka J; Meyenberger C; Arn M; Renner EL;
J Viral Hepat; 2006 Jul; 13(7):457-65. PubMed ID: 16792539
[TBL] [Abstract][Full Text] [Related]
19. Peginterferon and ribavirin for chronic hepatitis C.
Hoofnagle JH; Seeff LB
N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366
[No Abstract] [Full Text] [Related]
20. Comparison of low-dose pegylated interferon versus standard high-dose pegylated interferon in combination with ribavirin in patients with chronic hepatitis C with genotype 3: an Indian experience.
Sood A; Midha V; Hissar S; Kumar M; Suneetha PV; Bansal M; Sood N; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2008 Feb; 23(2):203-7. PubMed ID: 17645472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
